Diabetes
From the Journals
SGLT2 inhibitors linked with fewer gout flares in diabetes
“SGLT2 inhibitors may offer distinct benefits,” making the drug class “a particularly attractive addition to current urate-lowering therapies.”
Conference Coverage
Intermittent fasting vs. calorie counting for weight loss
“If you’ve tried calorie counting, that’s not working for you or if you’re kind of burnt out, this is something else that you could try.”
Clinical Inquiries
Does use of continuous or flash glucose monitors decrease hypoglycemia episodes in T2D?
EVIDENCE-BASED REVIEW: NO. In adults with insulin-treated type 2 diabetes (T2D), continuous glucose monitoring (CGM) and flash glucose monitoring...
From the Journals
How a heat wave affects glycemic control
“We hypothesized that people with diabetes, who are highly vulnerable, have more time for self-management as they spend more time indoors.”
Commentary
Goodbye, finger sticks; hello, CGMs
It’s easy to determine whether blood sugar is going up or down and the proportion of time the patient spends in or out of the target glucose range...
Latest News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
From the Journals
Meta-analysis finds increase in type 1 diabetes incidence, ketoacidosis during COVID pandemic
Data reported in 15 studies showed a 26% increase in DKA incidence during the first year of the pandemic.
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
From the Journals
Spirometry predicts mortality in type 2 diabetes
PRISm occurs in approximately 10% of the general population and has been identified as a predictor of adverse health outcomes.
Latest News
Evidence weighed for suicide/self-harm with obesity drugs
“It is not yet clear whether the reported cases are linked to the medicines themselves or to the patients’ underlying conditions or other factors...
Latest News
Link between low co-pays for new diabetes drugs and patient adherence
Low co-pays linked with substantially better 12-month adherence to expensive SGLT2 inhibitors and GLP-1 agonists in U.S. patients with type 2...